Barnett CP, Nataren NJ, Klingler-Hoffmann M, Schwarz Q, Chong CE, Lee YK, et al. Ectrodactyly and Lethal Pulmonary Acinar Dysplasia Associated with Homozygous FGFR2 Mutations Identified by Exome Sequencing. Human Mutation. 2016. 37 (9) : 955—63.
Polasek TM, Ambler K, Scott HS, Sorich MJ, Kaub PA, Rowland A, et al. Targeted pharmacotherapy after somatic cancer mutation screening. F1000Research. 2016. 5 : 1551.
De Sousa SM, Kassahn KS, McIntyre LC, Chong CE, Scott HS, Torpy DJ. Case report of whole genome sequencing in the XY female: identification of a novel SRY mutation and revision of a misdiagnosis of androgen insensitivity syndrome. BMC Endocrine Disorders. 2016. 16 (1) : 58.
Lopes BA, Meyer C, Barbosa TC, Zur Stadt U, Horstmann M, Venn NC, et al. COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia. Oncotarget. 2016. 7 (33) : 53064—53073.
Zaliova M, Moorman AV, Cazzaniga G, Stanulla M, Harvey RC, Roberts KG, et al. Characterization of leukemias with ETV6-ABL1 fusion. Haematologica. 2016. 101 (9) : 1082—93.
Stark Z, Tan T.Y, Chong B, Brett G.R, Yap P, Walsh M, et al. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genetics in Medicine. 2016. 18 (11) : 1090—96.
Newson A.J, Leonard S.J, Hall A, Gaff C.L. Known unknowns: building an ethics of uncertainty into genomic medicine. BMC Medical Genomics. 2016. 9 (1) : 57.
Sadedin S, Dashnow H, James P, Bahlo M, Bauer D, Lonie A, et al. Cpipe: a shared variant detection pipeline designed for diagnostic settings. Genome Medicine. 2015. 7 (1) : 68.